AMISULPRIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C17H27N3O4S
Molecular Weight	369.479
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of AMISULPRIDE

Structure Search

SMILES

CCN1CCCC1CNC(=O)C2=C(OC)C=C(N)C(=C2)S(=O)(=O)CC

InChI

InChIKey=NTJOBXMMWNYJFB-UHFFFAOYSA-N

InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)

HIDE SMILES / InChI

Molecular Formula	C17H27N3O4S
Molecular Weight	369.479
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:29:20 UTC 2023` Edited by `admin` on `Sat Dec 16 17:29:20 UTC 2023`
Record UNII	8110R61I4U
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AMISULPRIDE

Official Name

English

Amisulpride [WHO-DD]

Common Name

English

APD421

Code

English

BARHEMSYS

Brand Name

English

BENZAMIDE, 4-AMINO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-(ETHYLSULFONYL)-2-METHOXY-

Systematic Name

English

SULAMID

Brand Name

English

DAN-2163

Code

English

AMISULPRIDE [MI]

Common Name

English

APD-421

Code

English

SOLIAN

Brand Name

English

NSC-760085

Code

English

DENIBAN

Brand Name

English

(±)-AMISULPRIDE

Common Name

English

AMISULPRIDE [EP MONOGRAPH]

Common Name

English

SOCIAN

Brand Name

English

AMISULPRIDE [MART.]

Common Name

English

4-AMINO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-(ETHYLSULFONYL)-O-ANISAMIDE

Common Name

English

AMISULPRIDE [ORANGE BOOK]

Common Name

English

amisulpride [INN]

Common Name

English

AMINOSULTOPRIDE

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C66883

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

WHO-VATC

QN05AL05

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

WHO-ATC

N05AL05

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

Code System Code Type Description

EVMPD

SUB05458MIG

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

DAILYMED

8110R61I4U

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

INN

4960

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

USAN

FG-201

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

NCI_THESAURUS

C83533

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

CHEBI

64045

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

WIKIPEDIA

AMISULPRIDE

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

DRUG BANK

DB06288

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

ChEMBL

CHEMBL243712

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

MERCK INDEX

m1751

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

Merck Index

CAS

71675-85-9

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

FDA UNII

8110R61I4U

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

ECHA (EC/EINECS)

275-831-7

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

SMS_ID

100000087234

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

DRUG CENTRAL

179

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

IUPHAR

963

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

PUBCHEM

2159

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

RXCUI

46303

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

RxNorm

LACTMED

Amisulpride

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

EPA CompTox

DTXSID5042613

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

NSC

760085

Created by admin on Sat Dec 16 17:29:22 UTC 2023 , Edited by admin on Sat Dec 16 17:29:22 UTC 2023

PRIMARY

Related Record Type Details


					ES3TWM82E8

ENANTIOMER -> RACEMATE


					19GBD6T9L7

D(2) DOPAMINE RECEPTOR

TARGET->ANTAGONIST

Interaction Type:

SELECTIVE


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> INHIBITOR


					ONY583280Z

OCT-1

TRANSPORTER -> SUBSTRATE


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> SUBSTRATE


					G9XQ9S7T2F

D(3) DOPAMINE RECEPTOR

TARGET->ANTAGONIST

Interaction Type:

ANTAGONIST

Qualification:

Ki

Amount:


					B46KUN2O9L

MATE-2

TRANSPORTER -> INHIBITOR


					8110R61I4U

EXCRETED UNCHANGED

Interaction Type:

AMOUNT EXCRETED

Qualification:

URINE

Amount:


					B4J10KD2KI

ENANTIOMER -> RACEMATE


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Comments:

Plasma protein binding is 25% to 30% in the concentration range from 37 to 1850 ng/mL.

Interaction Type:

BINDING

Amount:


					8110R61I4U

EXCRETED UNCHANGED

Interaction Type:

AMOUNT EXCRETED

Qualification:

FECAL

Amount:


					76UB6O122H

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

TRANSPORTER -> SUBSTRATE


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

METABOLIC ENZYME -> SUBSTRATE


					B46KUN2O9L

MATE-2

METABOLIC ENZYME -> SUBSTRATE

Related Record Type Details


					NM73EV997H

N-METHYL AMISULPRIDE

IMPURITY -> PARENT

Related Record Type Details


					8110R61I4U

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC				FOLLOWING INTRAVENOUS INFUSION IN HEALTHY SUBJECTS

Volume of Distribution	PHARMACOKINETIC				IN SURGICAL PATIENTS FOLLOWING INTRAVENOUS INFUSION

Biological Half-life	PHARMACOKINETIC				IN HEALTHY SUBJECTS AND SURGICAL PATIENTS FOLLOWING INTRAVENOUS INFUSION